Figure 2From: Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease Serial change in sUA and eGFR before and after hypouricemic treatment. After initiation of hypouricemic treatment, mean sUA level decreased from 8.7 ± 0.9 to 5.7 ± 1.4 mg/dL in CKD stage 1-3a group, whereas from 8.8 ± 0.6 to 7.0 ± 0.9 mg/dL in CKD stage 3b-4 group. Mean eGFR level increased from 60.3 ± 16.1 to 62.6 ± 16.4 mL/min/1.73 m2 in CKD stage 1-3a group, whereas eGFR decreased from 29.1 ± 7.2 to 26.0 ± 10.0 mL/min/1.73 m2 in CKD stage 3b-4 group.Back to article page